Thomas Meth - 29 Jan 2024 Form 4 Insider Report for Enviva Inc.

Reporting relationship: President, Director
Issuer ticker: N/A
Reported as of: 29 Jan 2024
Net transaction value: -$2,167
SEC form: 4
Accepted by SEC: 31 Jan 2024, 21:57:23 UTC
Prior SEC filing: 20 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Jason E. Paral, as attorney-in-fact for Thomas Meth

Key filing fact

Thomas Meth filed Form 4 for Enviva Inc. on 31 Jan 2024.

Key facts

This page summarizes Thomas Meth's Form 4 filing for Enviva Inc..
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 31 Jan 2024, 21:57.

Change

Previous filing in this sequence was filed on 20 Jun 2023.
Current net transaction value: -$2,167.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVA transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +10,135
Change %: +2.1%
Price: $0.000000
Shares after: 483,303
Date: 29 Jan 2024
Ownership: Direct

EVA transaction

Common Stock

Tax liability

Transaction value: $2,167
Shares: -3,737
Change %: -0.77%
Price: $0.5800
Shares after: 479,566
Date: 29 Jan 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -10,135
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,135
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On January 29, 2024, the restricted stock units reported above vested in accordance with the Reporting Person's grant award and were settled through the issuance of an equal number of shares of common stock to the Reporting Person.